Basel, Switzerland, 2017-11-02 - NBE-Therapeutics presented update on R&D activities at 2017 HPAPI World Congress
Roger R. Beerli, CSO of NBE-Therapeutics, presented an update on the company's ADC development activities
Roger R. Beerli has been invited for a presentation at the High-Potency API (HPAPI) World Congress 2017. The conference is hosted by Terrapinn and takes place in Basel, Switzerland (see: http://www.terrapinn.com/conference/hpapi-world-congress/index.stm). Roger's presentation is entitled "Anthracycline-based antibodydrug conjugates with potent immune-stimulatory functions" and took place on November 2, at 2:40 pm.
Recent news feed
RSS feed from: